drugset / Trial / NCT00835627

Treatment Trial for Psychogenic Nonepileptic Seizures

NCT00835627

RandomizedSingle-groupSingle-blindTreatment

Summary

The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.

Timeline

Start
2008-09
Primary completion
2012-12
Completion
2013-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 200 mg